干扰素α鼻喷雾预防降低了癌症患者的COVID-19:随机,双盲,安慰剂控制的试验
Michelle K Yong1,2,3,4, Karin Thursky1,2,4,5, Megan Crane1,4
1Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
概括
每天喷干扰素-α (IFN-α) 显著降低了成人癌症患者的COVID-19发病率. 这种预防措施是安全的,耐受性很好,为这种易受感染的人群提供了潜在的新策略.
科学领域:
- 传染性疾病
- 癌症学
- 病毒学
背景情况:
- 成年癌症患者患有严重的COVID-19和其他呼吸道病毒感染的风险增加.
- 干扰素-α (IFN-α) 已知具有抗病毒性质.
- 评估预防性鼻IFN-α对于保护免疫受损的个体至关重要.
研究的目的:
- 确定每日鼻腔干扰素-α (IFN-α) 喷雾是否可以降低成人癌症患者的COVID-19发病率.
- 评估IFN-α鼻喷剂对其他社区获得的呼吸道病毒感染的疗效.
- 评估鼻IFN-α预防的安全性和耐受性.
主要方法:
- 一个多中心,随机,双盲,安慰剂对照试验.
- 参与者每天接受4万IU的IFN-α鼻喷剂或安慰剂.
- 用PCR和快速抗原测试检测有症状的个体.
主要成果:
- IFN-α鼻喷剂减少了COVID-19的发生率40% (RR: .60; 95% CrI: .33- .97).
- 两组之间没有观察到其他呼吸道病毒感染率的显著差异.
- 小组分析显示年轻 (< 65 岁),女性和接种疫苗的患者的益处更大.
结论:
- 鼻干扰素-α (IFN-α) 预防有效降低了成人癌症患者的COVID-19发病率.
- 治疗是安全的,耐受性很好,没有增加严重后果的风险.
- 对于高风险癌症群体来说,IFN-α鼻喷剂是一个有前途的预防措施.
相关概念视频
Cancer Vaccines
509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Tumor Immunotherapy
659
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Rous Sarcoma Virus (RSV) and Cancer
5.4K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.4K
siRNA - Small Interfering RNAs
17.0K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.0K


